NCT07564713

Brief Summary

Background: Lateral epicondylitis is a common musculoskeletal condition characterized by pain and functional impairment of the elbow, often associated with degenerative changes in the common extensor tendon. Extracorporeal shock wave therapy (ESWT) and low-level laser therapy (LLLT) are widely used noninvasive treatment modalities; however, comparative evidence regarding their clinical and structural effects remains limited. Objective: This study aims to compare the effects of ESWT and LLLT on pain intensity, elbow function, quality of life, grip strength, and ultrasonographic characteristics of the extensor tendon (thickness and echogenicity) in patients with lateral epicondylitis. Methods: This prospective, randomized, single-blind, comparative clinical trial will be conducted at the Physical Medicine and Rehabilitation outpatient clinic. Patients aged 18-65 years with clinically diagnosed lateral epicondylitis and symptom duration of at least six weeks will be included. All participants will receive a tennis elbow brace and a standardized exercise program. Participants will be randomly assigned to receive either ESWT or LLLT. ESWT will be applied to the lateral epicondyle region using a standardized protocol once weekly for 3 weeks. LLLT will be administered to the same region using standard clinical protocol three times per week for 3 weeks. Assessments will be performed before and after treatment. Pain will be evaluated using the Visual Analog Scale (VAS), elbow function using the Patient-Rated Tennis Elbow Evaluation (PRTEE), quality of life using the Short Form-36 (SF-36), and grip strength using a hand dynamometer. Ultrasonographic evaluation of the common extensor tendon will be performed by a blinded specialist using a high-frequency linear probe to assess tendon thickness.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
5mo left

Started Apr 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress6%
Apr 2026Sep 2026

First Submitted

Initial submission to the registry

April 27, 2026

Completed
2 days until next milestone

Study Start

First participant enrolled

April 29, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 4, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 29, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 29, 2026

Last Updated

May 4, 2026

Status Verified

April 1, 2026

Enrollment Period

5 months

First QC Date

April 27, 2026

Last Update Submit

April 27, 2026

Conditions

Keywords

Lateral epicondylitisextracorporeal shock wave therapyultrasonographylow-intensity laser therapytennis elbow

Outcome Measures

Primary Outcomes (1)

  • Pain intensity will be measured by the Visual Analog Scale (VAS)

    Pain intensity will be measured by the VAS, a 10-cm horizontal scale ranging from 0 (no pain) to 10 (worst imaginable pain). Participants will be asked to indicate their pain level, and the score will be recorded accordingly.

    Baseline and after 3 weeks of treatment

Secondary Outcomes (4)

  • Elbow function and pain-related disability will be assessed using the Patient-Rated Tennis Elbow Evaluation (PRTEE) questionnaire.

    Baseline and after 3 weeks of treatment

  • Quality of life will be assessed using the Short Form-36 (SF-36) questionnaire

    Baseline and after 3 weeks of treatment

  • Grip strength will be measured using a Jamar hand dynamometer

    Baseline and after 3 weeks of treatment

  • Ultrasonographic assessment of extensor tendon thickness

    Baseline and after 3 weeks of treatment

Study Arms (2)

ESWT Group

EXPERIMENTAL

Participants in the experimental group will receive a tennis elbow brace and a standardized exercise program, and additionally undergo extracorporeal shock wave therapy (ESWT). ESWT will be applied to the lateral epicondyle region over the common extensor tendon using a standardized protocol (1.6 bar, 2000 pulses, 10 Hz, once weekly for 3 weeks).

Behavioral: ESWT Group

LLLT Group

ACTIVE COMPARATOR

Participants in the active comparator group will receive a tennis elbow brace and a standardized exercise program, and additionally undergo low-level laser therapy (LLLT). LLLT will be applied to the lateral epicondyle region over the common extensor tendon using a standardized protocol three times per week for 3 weeks at four points, 40 seconds per point, with a dose of 4 J/cm².

Behavioral: LLLT Group

Interventions

ESWT GroupBEHAVIORAL

ESWT will be applied to the lateral epicondyle region using a standardized protocol for 3 sessions in three weeks

ESWT Group
LLLT GroupBEHAVIORAL

LLLT will be applied to the lateral epicondyle region using a standardized protocol three times per week for 3 weeks

LLLT Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of lateral epicondylitis based on physical examination findings
  • Symptom duration of at least 6 weeks
  • Presence of lateral elbow pain aggravated by wrist extension and/or gripping activities
  • Ability to understand and comply with study procedures
  • Provision of written informed consent

You may not qualify if:

  • Previous surgery involving the affected elbow
  • History of corticosteroid or other injection therapy to the affected elbow within the last 6 months
  • Presence of inflammatory rheumatic diseases (e.g., rheumatoid arthritis)
  • Neurological disorders affecting the upper extremity
  • Systemic inflammatory or metabolic diseases that may affect tendon structure or healing
  • Cervical radiculopathy or other causes of referred upper extremity pain
  • Pregnancy or breastfeeding
  • Use of anticoagulant therapy or bleeding disorders
  • Severe comorbid conditions that may interfere with participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Tennis Elbow

Condition Hierarchy (Ancestors)

Elbow TendinopathyTendinopathyMuscular DiseasesMusculoskeletal DiseasesElbow InjuriesArm InjuriesWounds and InjuriesTendon Injuries

Study Officials

  • Pınar Başaran, Dr

    Hitit University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Pınar Başaran, Dr

CONTACT

Ayşe Doğan, Ass Prof

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Single (Outcome assessor)
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly allocated in a 1:1 ratio to receive either extracorporeal shock wave therapy (ESWT) or low-level laser therapy (LLLT). In addition to the assigned intervention, all participants will be provided with a tennis elbow brace and a standardized exercise program.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

April 27, 2026

First Posted

May 4, 2026

Study Start

April 29, 2026

Primary Completion (Estimated)

September 29, 2026

Study Completion (Estimated)

September 29, 2026

Last Updated

May 4, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared due to institutional regulations and the absence of participant consent for public data sharing.